While lifestyle choices and environment can impact risk, genes are often what most affect how likely a person is to develop a disease. People commonly have diff...
Continue reading
For most clinical programs, recruitment is the single largest source of delay. It is often more operationally complex than the trial itself, and when it underpe...
Continue reading
CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-associated (Cas) proteins were first characterized as part of bacterial immune def...
Continue reading
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a progressive liver disease driven by fat a...
Continue reading
Pharmacogenomics, also known as pharmacogenetics, is a field of research dedicated to investigating how an individual's genetic makeup influences their response...
Continue reading
This webinar, hosted by Sano CEO Dr. Patrick Short and featuring Dr. Dimitar Tonev, an expert in liver disease and hepatology, sheds light on the latest develop...
Continue reading
Keeping participants engaged in clinical research can be difficult. Here, we let the statistics tell the story:
Continue reading
Genetic data is at the heart of precision medicine. Understanding the influence of genetics on health has helped us to identify risk factors for disease, predic...
Continue reading
DPharm 2023 has come to a close, and as we reflect on the sessions and insights shared, two themes clearly stood out this year: The participant experience and i...
Continue reading
As COVID-19 continues to affect us all, it has become evident that our fight against the virus is not just about developing vaccines and therapeutics. Equally c...
Continue reading